Conference on Pharma Anti-Counterfeiting 2012


Counterfeit Pharmaceuticals do not only provoke immense economic damage to pharmaceutical companies but are a great risk to the public. The increasing threat calls for immediate action against counterfeit medicines. Steps must be taken by governmental and international authorities as well as by every single affected pharmaceutical company. Counterfeit APIs and medicines pose a growing threat to patients worldwide, with increasing numbers in Europe and the USA. Customs all over the world find more and more illegally produced drugs. Moreover, drugs are increasingly sold via the Internet making it much easier to put counterfeits into circulation.

Counterfeiting of drugs and medical devices cost the pharmaceutical and medical device industry billions of dollars annually in lost revenues. This loss is amplified by the serious threats fake drugs pose to the health and safety of consumers. Directing your organization toward an successful brand protection system can be a daunting task given the sophistication of counterfeiters and the difficulty in tracking and prosecuting perpetrators. This in-depth workshop will teach you how to ensure you have a solid counterfeit program and help you to gain a better understanding of how to develop an efficient brand protection program. It is estimated that counterfeiting is a $600 billion a year problem. In fact, it’s a problem that has grown over 10,000% in the past two decades, in part fuelled by CONSUMER DEMAND. The real truth is people who purchase counterfeit merchandise risk funding nefarious activities, contributing to unemployment, creating budget deficits and compromising the future of this country in the global economy.

The real truth is counterfeiters are hardened criminals, exploiting consumers, businesses both large and small, inventors and artists and children labouring in sweatshops in Third World countries.

The Facts:

• Counterfeiting costs U.S. businesses $200 billion to $250 billion annually.
• Counterfeit merchandise is directly responsible for the loss of more than 750,000 American jobs.
• Since 1982, the global trade in illegitimate goods has increased from $5.5 billion to approximately $600 billion annually.
• Approximately 5%-7% of the world trade is in counterfeit goods.
• U.S. companies suffer $9 billion in trade losses due to international copyright piracy.
• Counterfeiting poses a threat to global health and safety.

This conference will gather government bodies, pharmaceutical companies and solution and technology providers to discuss the in-depth insights into the strategies and cutting edge technologies for pharmaceutical anti-counterfeiting.

It gives us immense pleasure in welcoming you to “Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits in EU & USA”


• Anti-Counterfeiting and Product Security in EU and USA: government policies & strategies
• Identifying current developments in counterfeits & ways to overcome threats
• Discovering successful business models - Opportunities & Challenges
• Identify main challenges and methods to improve Global Security
• International partnerships and EU & U.S. regulations to combat counterfeit medicines
• Practical Tips - Strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement
• Best Practices on risk based approach to predict & prevent counterfeiting
• Protect your products - Learn how to use the right packaging identification systems effectively
• Discuss the impact of parallel trade and re-imports on counterfeiting medicines
• Effective drug packaging design and technologies enhancing product efficiency, patient and health personnel security, compliance, ease of use Global Market Analysis
• Establish robust pharmaceutical anti-counterfeiting and brand protection strategy to protect product and brand revenue
• Involve the latest cutting edge serialisation & track & trace technologies for anti-counterfeiting
• Include anti-counterfeiting in your business plan in order to secure product and supply chain safety in your company
• How the FBI is currently addressing intellectual property crime and partnering with U.S. government agencies
• Network in our combined exhibition and catering area
• Evening networking reception for all attendees


Brand Protection & Enforcement Units

VPs, Heads, Directors and Managers with the following responsibilities:

Anti-Counterfeiting Operations
Brand Protection
Brand Enforcement
Brand Security
Brand Integrity
Brand Management
Corporate Security
Global Security
Intellectual Property
Trademark Protection

Supply Chain

VPs, Heads, Directors and Managers with the following responsibilities:

Supply Chain
Product Safety, Regulation & Quality
Quality Assurance
Track and Trace
Manufacturing Technologies


“Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.


08:30 – Coffee and registration

09:20 – Morning Chair’s opening remarks

Mark Davison, CEO, Blue Sphere Health

09:30 – Morning Keynote Address 1: Topic TBC

Steve Allen, Senior Director, Global Security, EMEA Pfizer

10:00 – Morning Keynote Address 2 – "Case studies of counterfeit medicines entering the legitimate Supply Chain from an AstraZeneca perspective”

• Specific AstraZeneca case studies involving counterfeit medicines and the supply chain
• Examples from UK and across EMEA region
• How AZ manages the issue of “Supply Chain Integrity”
• Key risks and how AZ mitigate them

Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZeneca

10:30 – Morning Keynote Panel Discussion: Challenges and Opportunities

As globalization has created more steps between production and consumption of pharmaceuticals, manufacturers have implemented various approaches to detect and prevent counterfeit products. A combination of anti-tamper, serialization and authentication technologies can be used to detect real versus counterfeit products, creating several layers of security for original pharmaceutical producers.

• The Dark Side of Globalization: Conquering counterfeit medicine now requires a global solution
• Advice to brand owners about how to coordinate/participate in government efforts
• Internet Buying: Is it so Dangerous? How to make it safer and thus bring the benefits of Internet prices to all.
• Identifying the scope of the problem of counterfeit medicines and medical devices